Gladstone Capital Corporation Preferred Stock September 2017

We represented Gladstone Capital Corporation in its public offering of 1,800,000 shares of its 6.00% series 2024 term preferred stock with proceeds of $51,800,000. Underwriters included Janney Montgomery Scott; Ladenburg Thalmann; FBR; BB&T Capital Markets; J.J.B. Hilliard; W.L. Lyons, LLC; Wedbush Securities; and William Blair.

Gladstone Capital Corporation (NASDAQ: GLAD) is a business development company that invests in debt and equity securities consisting primarily of secured first and second lien term loans to small and medium sized businesses in the United States.

You Also May Be Interested In:

  • Representation of AutoZone, Inc. (NYSE: AZO) in a public offering of $500,000,000 of 3.625% Senior Notes due 2025 and $750,000,000 of 4.000% Senior Notes due 2030

    We represented AutoZone, Inc. in a public offering of $500,000,000 of 3.625% Senior Notes due 2025 and $750,000,000 of 4.000%...
    Client Type: Public Company
  • We represented Pharos Capital’s post-acute care provider platform, Charter Health Care Group, in its acquisition of two hospice service providers,...
    Client Type: Private Company
  • Representation of axialHealthcare, a care optimization platform navigating substance use issues for patients, providers, and health plans, in a $15 million Series C round of financing to accelerate its expansion into the substance use disorder (SUD) treatment, and recovery sector. Previous institutional investors Oak HC/FT, .406 Ventures, BlueCross BlueShield Venture Partners (BCBSVP), and Sandbox Advantage Fund led the round.

    We represented axialHealthcare, a care optimization platform navigating substance use issues for patients, providers, and health plans, in a $15...
    Client Type: Private Company